There are 2949 resources available
918MO - Molecular enrichment and outcomes based on ESCAT levels in metastatic salivary gland tumours (mSGT) patients (pts) treated in early clinical trials
Presenter: Alberto Hernando-Calvo
Session: Mini Oral - Head & neck cancer
Resources:
Abstract
Slides
Webcast
919MO - ACCURACY a phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut)
Presenter: Renata Ferrarotto
Session: Mini Oral - Head & neck cancer
Resources:
Abstract
Slides
Webcast
277MO - SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in ER+/ HER2- metastatic breast cancer (mBC): Biomarker analyses from a phase I/II study
Presenter: Sarat Chandarlapaty
Session: Mini Oral - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
278MO - cfDNA analysis from phase I/II study of lerociclib (G1T38), a continuously dosed oral CDK4/6 inhibitor, with fulvestrant in HR+/HER2- advanced breast cancer patients
Presenter: Boris Krastev
Session: Mini Oral - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
279MO - Divergent evolution of overall survival across metastatic breast cancer (MBC) subtypes in the nationwide ESME real life cohort 2008-2016
Presenter: Suzette Delaloge
Session: Mini Oral - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
5MO - Prospective validation of a radiomics signature for chemoradiotherapy lung cancer patients
Presenter: Ralph Leijenaar
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
7MO - Photoreactive and intratumorally injectable dendrimer matrix improves survival in multiple xenograft mouse models
Presenter: Sauli Vuoti
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
8MO - Effective tumour growth control by combined vaccine-immune-checkpoint inhibition in MLH1-/- mice
Presenter: Claudia Maletzki
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
1978MO - Tumour-infiltrating macrophages, PD-L1 and tumour/stroma ratio as independent prognostic factors in a well-defined European cohort of patients with oral squamous cell carcinoma
Presenter: Pieter Demetter
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
1979MO - Inhibition of fatty acid synthase (FASN) activity induces cytotoxicity on gefitinib- and osimertinib-resistant EGFR-mutated non-small cell lung cancer cells
Presenter: Emma Polonio
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast